Live Breaking News & Updates on Multimodal Outcomes|Page 1

Stay updated with breaking news from Multimodal outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioVie's degenerative dementia drug candidate to be presented at the 78th Annual Scientific Convention of the Society of Biological Psychiatry.

BioVie Inc (NASDAQ:BIVI) announced Thursday that a data abstract from its Phase 2 open-label trial of its degenerative dementia drug candidate has been. ....

United States , San Diego , Andrew Kessel , American Academy Of Neurology Annual Meeting , Biovie Inc , Annual Scientific Convention , Multimodal Outcomes , Open Label Study , Cognitive Decline Due , Degenerative Dementias , Neurology Annual Meeting ,